Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 12.275 USD -0.2% Market Closed
Market Cap: 785.1m USD
Have any thoughts about
Avid Bioservices Inc?
Write Note

Avid Bioservices Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Avid Bioservices Inc
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Avid Bioservices Inc
NASDAQ:CDMO
Total Receivables
$30.2m
CAGR 3-Years
12%
CAGR 5-Years
17%
CAGR 10-Years
24%
Abbvie Inc
NYSE:ABBV
Total Receivables
$11.5B
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Total Receivables
$4.6B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Total Receivables
$7.3B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Receivables
$1.8B
CAGR 3-Years
17%
CAGR 5-Years
32%
CAGR 10-Years
31%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Receivables
$6.1B
CAGR 3-Years
4%
CAGR 5-Years
18%
CAGR 10-Years
21%
No Stocks Found

Avid Bioservices Inc
Glance View

Market Cap
785.1m USD
Industry
Biotechnology

Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

CDMO Intrinsic Value
17.564 USD
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Avid Bioservices Inc's Total Receivables?
Total Receivables
30.2m USD

Based on the financial report for Oct 31, 2024, Avid Bioservices Inc's Total Receivables amounts to 30.2m USD.

What is Avid Bioservices Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
24%

Over the last year, the Total Receivables growth was 25%. The average annual Total Receivables growth rates for Avid Bioservices Inc have been 12% over the past three years , 17% over the past five years , and 24% over the past ten years .

Back to Top